TrueBinding, Inc.: Clinical Trials

3 trials sponsored by TrueBinding, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Withdrawn 1
Phase 21Completed 1

Follow TrueBinding, Inc.: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease
TB006, Placebo - Alzheimer's Disease
Phase 1 / Phase 2CompletedTrueBinding, Inc.1542021-10-082023-11-18
Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects
TB006, Sterile saline (Placebo) - Alzheimer Disease
Phase 1CompletedTrueBinding, Inc.482021-06-012024-12-09
Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19
TB006, Placebo - Covid19
Phase 1WithdrawnTrueBinding, Inc.2021-06-012022-05-18

Conditions studied

Alzheimer Disease (2)  ·  COVID-19 (1)

Interventions

TB006 (3)

Countries

United States (2)

Top investigators

David Walling, MD (1)  ·  George Haig, PharmD (1)